Meeting
2016 Gastrointestinal Cancers Symposium
Clinical study on medical value of adoptive immunotherapy with chemotherapy for stage IV colorectal cancer (COMVI study).
Authors
Yoichiro Yoshida
Department of Gastroenterological Surgery, Fukuoka University School of Medicine, Fukuoka, Japan
Yoichiro Yoshida , Masayasu Naito , Teppei Yamada , Naoya Aisu , Daibo Kojima , Toshiyuki Mera , Syu Tanimura , Toshihiro Tanaka , Keiko Naitoh , Kosei Yasumoto , Takashi Kamigaki , Shigenori Goto , Yuichi Yamashita
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Translational Research
Clinical Trial Registration Number
UMIN000010908
Citation
J Clin Oncol 34, 2016 (suppl 4S; abstr 628)
DOI
10.1200/jco.2016.34.4_suppl.628
Abstract #
628
Poster Bd #
G11
Abstract Disclosures
Similar Posters
Poster
2016 Gastrointestinal Cancers Symposium
Phase II study of the early start of chemotherapy after excision of primary colorectal cancer with distant metastases (Pearl Star 02).
First Author: Syu Tanimura
Poster
2014 Gastrointestinal Cancers Symposium
The safety of chemotherapy for colorectal cancer patients with hepatitis C virus infection.
First Author: Kenji Tomizawa
Poster
2024 ASCO Annual Meeting
Fruquintinib plus capecitabine versus capecitabine as first-line maintenance treatment of metastatic colorectal cancer (mCRC): Update results from the randomized, controlled, phase Ib/II study.
First Author: Wenhua Li
Poster
2024 ASCO Annual Meeting
GEMINI-Gastric: A phase 2 study of novel treatment combinations in patients with locally advanced unresectable or metastatic gastric cancers.
First Author: Lin Shen